Older Men Are as Responsive as Young Men to the Anabolic Effects of Graded Doses of Testosterone on the Skeletal Muscle
The DOI matches its Crossref record; 72 of the 73 references it cites were found in a registry or an index.
Abstract
Although testosterone levels and muscle mass decline with age, many older men have serum testosterone level in the normal range, leading to speculation about whether older men are less sensitive to testosterone. We determined the responsiveness of androgen-dependent outcomes to graded testosterone doses in older men and compared it to that in young men. The participants in this randomized, double-blind trial were 60 ambulatory, healthy, older men, 60-75 yr of age, who had normal serum testosterone levels. Their responses to graded doses of testosterone were compared with previous data in 61 men, 19-35 yr old. The participants received a long-acting GnRH agonist to suppress endogenous testosterone production and 25, 50, 125, 300, or 600 mg testosterone enanthate weekly for 20 wk. Fat-free mass, fat mass, muscle strength, sexual function, mood, visuospatial cognition, hormone levels, and safety measures were evaluated before, during, and after treatment. Of 60 older men who were randomized, 52 completed the study. After adjusting for testosterone dose, changes in serum total testosterone (change, -6.8, -1.9, +16.1, +49.5, and +101.9 nmol/liter at 25, 50, 125, 300, and 600 mg/wk, respectively) and hemoglobin (change, -3.6, +9.9, +20.9, +12.6, and +29.4 g/liter at 25, 50, 125, 300, and 600 mg/wk, respectively) levels were dose-related in older men and significantly greater in older men than young men (each P < 0.0001). The changes in FFM (-0.3, +1.7, +4.2, +5.6, and +7.3 kg, respectively, in five ascending dose groups) and muscle strength in older men were correlated with testosterone dose and concentrations and were not significantly different in young and older men. Changes in fat mass correlated inversely with testosterone dose (r = -0.54; P < 0.001) and were significantly different in young vs. older men (P < 0.0001); young men receiving 25- and 50-mg doses gained more fat mass than older men (P < 0.0001). Mood and visuospatial cognition did not change significantly in either group. Frequency of hematocrit greater than 54%, leg edema, and prostate events were numerically higher in older men than in young men. Older men are as responsive as young men to testosterone's anabolic effects; however, older men have lower testosterone clearance rates, higher increments in hemoglobin, and a higher frequency of adverse effects. Although substantial gains in muscle mass and strength can be realized in older men with supraphysiological testosterone doses, these high doses are associated with a high frequency of adverse effects. The best trade-off was achieved with a testosterone dose (125 mg) that was associated with high normal testosterone levels, low frequency of adverse events, and significant gains in fat-free mass and muscle strength.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There are conflicting data on the effect of testosterone supplementation on muscle strength and function50,51,357,414.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [414]
In the citing paper
“Testosterone has a dose-dependent impact on fat-free mass in both the young and old, with higher levels associated with reduction in fat mass and increase in skeletal muscle mass and strength [43].”
From Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review (2019) · cites this paper as [43]
Citations
Cites
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760
Feldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., & McKinlay, J. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8201 · Cited by 1,861
The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men
Bhasin, S., Storer, T. W., Berman, N., Callegari, C., Clevenger, B., Phillips, J., Bunnell, T. J., Tricker, R., Shirazi, A., & Casaburi, R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607043350101 · Cited by 1,659
Self-citationAging of skeletal muscle: a 12-yr longitudinal study
Frontera, W. R., Hughes, V. A., Fielding, R. A., Fiatarone, M. A., Evans, W. J., & Roubenoff, R. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.4.1321 · Cited by 1,443
GRAY, A., FELDMAN, H. A., MCKINLAY, J. B., & LONGCOPE, C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1016 · Cited by 1,118
Testosterone dose-response relationships in healthy young men
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., et al. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1172 · Cited by 967 · cited 7×
“The characteristics of young men have been described previously (29).”
BackgroundMethodResultInfluentialSelf-citationTestosterone Replacement in Older Hypogonadal Men: A 12-Month Randomized Controlled Trial
Sih, R. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.6.1661 · Cited by 922
Hughes, V. A., Frontera, W. R., Wood, M., Evans, W. J., Dallal, G. E., Roubenoff, R., & Singh, M. A. F. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.5.b209 · Cited by 921
Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women
Iannuzzi-Sucich, M., Prestwood, K. M., & Kenny, A. M. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.12.m772 · Cited by 890
Morley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., Morley, P. M. K., Stauber, P. M., Vellas, B., Baumgartner, R. N., & Garry, P. J. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90057-3 · Cited by 830
Cited by
Items 101–200 of 554
Chapman, I. M., Visvanathan, R., Hammond, A. J., Morley, J. E., Field, J. B., Tai, K., Belobrajdic, D. P., Chen, R. Y. T., & Horowitz, M. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26538 · Cited by 103
Soisson, V., Brailly‐Tabard, S., Helmer, C., Rouaud, O., Ancelin, M., Zerhouni, C., Guiochon‐Mantel, A., & Scarabin, P. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.04.012 · Cited by 105
O’Donnell, A. B., Travison, T. G., Harris, S. S., Tenover, J. L., & McKinlay, J. B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1227 · Cited by 94
“(20), who found substantial gains in muscle mass”
BackgroundTestosterone and weight loss: the evidence
Traish, A. M. (2014) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000086 · Cited by 94
Effects of Muscle Strength Training and Testosterone in Frail Elderly Males
SULLIVAN, D. H., ROBERSON, P. K., JOHNSON, L. E., BISHARA, O., EVANS, W. J., SMITH, E. S., & PRICE, J. A. (2005) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000181840.54860.8b · Cited by 94
“Several recent studies that demonstrated strength improvements with testosterone therapy in healthy older men provided the intervention from 5 to 36 months (7,20).”
BackgroundBauer, J. M., Cruz-Jentoft, A. J., Fielding, R. A., Kanis, J. A., Reginster, J.-Y., Bruyère, O., Cesari, M., Chapurlat, R., Al-Daghri, N., Dennison, E., et al. (2019) · Calcified Tissue International · doi:10.1007/s00223-019-00561-w · Cited by 83
Chang, C., Yeh, S., Lee, S. O., & Chang, T.-M. (2013) · Nuclear Receptor Signaling · doi:10.1621/nrs.11001 · Cited by 91
“Exogenous testosterone administration has been shown to increase the muscle mass and leg strength and decrease the fat mass in eugonadal young and aging men [Bhasin et al., 2001; Bhasin et al., 2005].”
BackgroundMadsen, M. C., van Dijk, D., Wiepjes, C. M., Conemans, E. B., Thijs, A., & den Heijer, M. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab089 · Cited by 108
“The lowering of this upper limit is based on studies that show that older men have a higher risk of developing erythrocytosis (31, 34).”
BackgroundThe Rationale for Banning Human Chorionic Gonadotropin and Estrogen Blockers in Sport
Handelsman, D. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2569 · Cited by 90
“Nowadays the strongest and most coherent justification for banning androgens as performance-enhancing agents is derived from these studies that showed unequivocally for the first time that: 1) testosterone at supraphysiological doses and blood concentrations increases muscle mass and strength in healthy eugonadal men…”
BackgroundThe role of GH and IGF-I in mediating anabolic effects of testosterone on androgen-responsive muscle
Serra, C., Bhasin, S., Tangherlini, F., Barton, E. R., Ganno, M., Zhang, A., Shansky, J., Vandenburgh, H. H., Travison, T. G., Jasuja, R., et al. (2011) · Endocrinology · doi:10.1210/en.2010-0802 · Cited by 78
Self-citationIdan, A., Griffiths, K. A., Harwood, D. T., Seibel, M. J., Turner, L., Conway, A. J., & Handelsman, D. J. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-10-201011160-00004 · Cited by 89
Endocrinological derangements in COPD
Laghi, F. A., Adıgüzel, N., & Tobin, M. J. (2009) · European Respiratory Journal · doi:10.1183/09031936.00103708 · Cited by 103
Legros, J.-J., Meuleman, E. J. H., Elbers, J. M. H., Geurts, T. B. P., Kaspers, M. J. G. H., Bouloux, P. M. G., & _, _. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0634 · Cited by 87
Bhasin, S., Ellenberg, S. S., Storer, T. W., Basaria, S., Pahor, M., Stephens-Shields, A. J., Cauley, J. A., Ensrud, K. E., Farrar, J. T., Cella, D., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30171-2 · Cited by 87
Self-citationCirculating protein synthesis rates reveal skeletal muscle proteome dynamics
Shankaran, M., King, C. L., Angel, T. E., Holmes, W. E., Li, K. W., Colangelo, M., Price, J. C., Turner, S. M., Bell, C., Hamilton, K. L., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79639 · Cited by 87
Undernutrition and Anorexia in the Older Person
Visvanathan, R., & Chapman, I. M. (2009) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2009.06.009 · Cited by 102
Araujo, A. B., Travison, T. G., Bhasin, S., Esche, G. R., Williams, R. E., Clark, R. V., & McKinlay, J. B. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01965.x · Cited by 82
Self-citationSarcopenia and Androgens: A Link between Pathology and Treatment
Basualto-Alarcón, C., Varela, D., Duran, J., Maass, R., & Estrada, M. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00217 · Cited by 79
“In one study, TRT increased bone mass only in the group of patients with hypogonadism (89).”
BackgroundEndocrinological Roles for Testosterone in Resistance Exercise Responses and Adaptations
Hooper, D. R., Kraemer, W. J., Focht, B. C., Volek, J. S., DuPont, W. H., Caldwell, L. K., & Maresh, C. M. (2017) · Sports Medicine · doi:10.1007/s40279-017-0698-y · Cited by 91
Discovery of Diarylhydantoins as New Selective Androgen Receptor Modulators
Nique, F., Hebbe, S., Peixoto, C., Annoot, D., Lefrançois, J.-M., Duval, E., Michoux, L., Triballeau, N., Lemoullec, J.-M., Mollat, P., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300249m · Cited by 87
Rana, K., Fam, B. C., Clarke, M. V., Pang, T. P. S., Zajac, J. D., & MacLean, H. E. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00584.2010 · Cited by 78
Relationship between Testosterone and Sarcopenia in Older-Adult Men: A Narrative Review
Shigehara, K., Kato, Y., Izumi, K., & Mizokami, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11206202 · Cited by 92
“In addition, a higher dose of testosterone can affect muscle mass and strength, not only for hypogonadal men but also eugonadal older men and healthy young men [86].”
BackgroundIndirect androgen doping by oestrogen blockade in sports
Handelsman, D. J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.150 · Cited by 84
“…concentrations as a valid surrogate measure for androgenic effects of indirect androgen doping (Handelsman, 2006), following the studies of Bhasin et al. (1996, 2001, 2005) showing that testosterone has wide dosedependent effects on muscle mass and strength (Storer et al., 2003; Woodhouse…”
BackgroundMorphological variation in dentate and edentulous human mandibles
Chrcanovic, B. R., de Abreu, M. H. N. G., & Custódio, A. L. N. (2010) · Surgical and Radiologic Anatomy · doi:10.1007/s00276-010-0731-4 · Cited by 77
“Testosterone exerts dose-dependent anabolic effects on bone [45] and muscle [5].”
Office Management of Weight Loss in Older Persons
Rolland, Y., Kim, M.-J., Gammack, J. K., Wilson, M. G., Thomas, D. R., & Morley, J. E. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.02.039 · Cited by 88
Fui, M. N. T., Hoermann, R., Bracken, K., Handelsman, D. J., Inder, W. J., Stuckey, B. G. A., Yeap, B. B., Ghasemzadeh, A., Robledo, K. P., Jesudason, D. R., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab149 · Cited by 83
“For example, dose-dependent testosterone effects on muscle mass and strength extend well into the supraphysiologic range (44, 45).”
Schoenfeld, B. J. (2013) · Journal of Strength and Conditioning Research · doi:10.1519/jsc.0b013e31828ddd53 · Cited by 74
“Numerous studies have shown that exogenous testosterone administration can promote marked increases in skeletal muscle hypertrophy (9,10,71), and these effects are magnified when combined with resistance exercise (11).”
BackgroundThe evolution and expression of virulence
Ebert, D., & Bull, J. J. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0012 · Cited by 83
Polyamines, androgens, and skeletal muscle hypertrophy
Lee, N. K. L., & MacLean, H. E. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22569 · Cited by 80
“Menwith decreased skeletal musclemass resulting from aging, hypogonadism, AIDS, or burns, may benefit from testosterone replacement therapy to increase muscle mass (Bhasin et al., 1997; Bhasin et al., 2000; Hart et al., 2001; Bhasin et al., 2005).”
BackgroundNational Athletic Trainers' Association Position Statement: Anabolic-Androgenic Steroids
Kersey, R. D., Elliot, D. L., Goldberg, L., Kanayama, G., Leone, J. E., Pavlovich, M., & Pope, H. G. (2012) · Journal of Athletic Training · doi:10.4085/1062-6050-47.5.08 · Cited by 73
Horwath, O., Apró, W., Moberg, M., Godhe, M., Helge, T., Ekblom, M., Hirschberg, A. L., & Ekblom, B. (2020) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00893.2019 · Cited by 70
“It is consistently shown that testosterone administration in men increases strength and muscle 400 mass (5, 59), and mitigates muscle wasting during ageing or clinical conditions (7, 20, 25).”
BackgroundSarcopenia: An Endocrine Disorder?
McKee, A. M., Morley, J. E., Matsumoto, A. M., & Vinik, A. I. (2017) · Endocrine Practice · doi:10.4158/ep171795.ra · Cited by 80
Fitness Consequences of Increased Testosterone Levels in Female Spotless Starlings
Veiga, J. P., & Polo, V. (2008) · The American Naturalist · doi:10.1086/587850 · Cited by 76
GSK2881078, a SARM, Produces Dose-Dependent Increases in Lean Mass in Healthy Older Men and Women
Neil, D., Clark, R. V., Magee, M., Billiard, J., Chan, A., Xue, Z., & Russell, A. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02644 · Cited by 68
Body composition, metabolic syndrome and testosterone in ageing men
Allan, C. A., Strauss, B. J. G., & McLachlan, R. I. (2007) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901552 · Cited by 67
Benefits and Risks of Testosterone Treatment in Men with Age-Related Decline in Testosterone
dos Santos, M. R., & Bhasin, S. (2020) · Annual Review of Medicine · doi:10.1146/annurev-med-050219-034711 · Cited by 78
Self-citationCurrent Guidelines for the Diagnosis of Testosterone Deficiency
Arver, S., & Lehtihet, M. (2008) · Frontiers of Hormone Research · doi:10.1159/000175839 · Cited by 67
Wiren, K. M., Semirale, A. A., Zhang, X.-W., Woo, A., Tommasini, S. M., Price, C., Schaffler, M. B., & Jepsen, K. J. (2008) · Bone · doi:10.1016/j.bone.2008.04.026 · Cited by 65
“Notably, an anabolic effect of androgen treatment on bone in eugonadal men (or in women) has not been observed, in contrast to known anabolic dose-dependent effects to increase muscle mass [5].”
ResultPaez, H. G., Pitzer, C. R., & Alway, S. E. (2023) · Cells · doi:10.3390/cells12020249 · Cited by 79
“The administration of exogenous testosterone, while known to substantially enhance skeletal muscle mass [243], is also associated with adverse outcomes regarding prostate health [244].”
Yarrow, J. F., McCoy, S. C., & Borst, S. E. (2010) · Steroids · doi:10.1016/j.steroids.2010.01.019 · Cited by 80
Neto, W. K., Gama, E. F., Rocha, L. Y., Ramos, C. C., Taets, W., Scapini, K. B., Ferreira, J. B., Rodrigues, B., & Caperuto, É. (2015) · AGE · doi:10.1007/s11357-014-9742-0 · Cited by 64
“Bhasin et al. (2005)) in a randomized double blind controlled study used testosterone enanthate and reported that it is the only formulation able to raise its levels to a supraphysiological level.”
BackgroundTestosterone Dose Dependently Prevents Bone and Muscle Loss in Rodents after Spinal Cord Injury
Yarrow, J. F., Conover, C. F., Beggs, L. A., Beck, D. T., Otzel, D. M., Balaez, A., Combs, S. M., Miller, J. R., Ye, F., Aguirre, J. I., et al. (2013) · Journal of Neurotrauma · doi:10.1089/neu.2013.3155 · Cited by 65
“45 Interestingly, both TE doses that we administered fully prevented LABC muscle loss after SCI, while only high-dose TE ameliorated hindlimb muscle loss.”
Borst, S. E., & Yarrow, J. F. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00111.2015 · Cited by 62
“The benefits with even higher doses of im T (300–600 mg/wk) are even more substantial (upward of 20% increase in 1-RM strength in older men over 20 wk), but the number of adverse events observed at these doses precludes their clinical implementation (14).”
BackgroundTherapeutic approaches to osteosarcopenia: insights for the clinician
Fatima, M., Brennan-Olsen, S. L., & Duque, G. (2019) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x19867009 · Cited by 88
Traustadóttir, T., Harman, S. M., Tsitouras, P. D., Pencina, K. M., Li, Z., Travison, T. G., Eder, R. V., Miciek, R., McKinnon, J., Woodbury, E. A., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01902 · Cited by 60
Self-citationLow serum testosterone and frailty in older men and women
Wu, I., Lin, X., Liu, P.-F., Tsai, W.-L., & Shiesh, S. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.07.010 · Cited by 69
Androgens and athletic performance of elite female athletes
Bermon, S. (2017) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000335 · Cited by 58
Pharmacological Treatment of Geriatric Cachexia: Evidence and Safety in Perspective
Yeh, S., Lovitt, S., & Schuster, M. W. (2007) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2007.05.001 · Cited by 59
“The frequency of a higher hematocrit ( 54%), leg edema, and prostate events (exacerbation of prostate cancer) were more significant in older men.(112) Although older men can gain substantial muscle mass and strength with supraphysiological testosterone doses, they also experience a high frequency of the above noted ad…”
BackgroundInfluentialBasaria, S., Davda, M. N., Travison, T. G., Ulloor, J., Singh, R., & Bhasin, S. (2013) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/gls138 · Cited by 57
Self-citationParahiba, S. M., Ribeiro, É. C. T., Corrêa, C., Bieger, P., Perry, I. D. S., & Souza, G. C. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111106 · Cited by 66
Sattler, F., Bhasin, S., He, J., Chou, C.-P., Castaneda-Sceppa, C., Yarasheski, K., Binder, E., Schroeder, E. T., Kawakubo, M., Zhang, A., et al. (2011) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glq183 · Cited by 57
Self-citationTestosterone-induced hypertrophy of L6 myoblasts is dependent upon Erk and mTOR
Wu, Y., Bauman, W. A., Blitzer, R. D., & Cardozo, C. P. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.08.127 · Cited by 61
Schnabel, P. G., Bagchus, W., Lass, H., Thomsen, T., & Geurts, T. B. P. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02781.x · Cited by 56
Knapp, P. E., Storer, T. W., Herbst, K. L., Singh, A. B., Dzekov, C., Dzekov, J., LaValley, M., Zhang, A., Ulloor, J., & Bhasin, S. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90213.2008 · Cited by 56
“Studies in non-HIV-infected men have generally shown a significant decrease in fat mass with testosterone treatment; body weight often does not change because of reciprocal changes in lean and fat mass (8, 10, 11, 34).”
BackgroundSelf-citationAging and androgens: Physiology and clinical implications
Anawalt, B. D., & Matsumoto, A. M. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09765-2 · Cited by 55
Testosterone boosts physical activity in male mice via dopaminergic pathways
Jardí, F., Laurent, M. R., Kim, N., Khalil, R., De Bundel, D., Van Eeckhaut, A., Van Helleputte, L., Deboel, L., Dubois, V., Schollaert, D., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-19104-0 · Cited by 55
Effects of testosterone and nandrolone on cardiac function: a randomized, placebo‐controlled study
Chung, T., Kelleher, S., Liu, P. Y., Conway, A. J., Kritharides, L., & Handelsman, D. J. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02715.x · Cited by 55
Do low testosterone levels contribute to ill-health during male ageing?
Yeap, B. B., de Araújo, A. B., & Wittert, G. (2012) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2012.725461 · Cited by 53
Responsiveness of the reproductive axis to a single missed evening meal in young adult males
Trumble, B. C., Brindle, E., Kupsik, M., & O’Connor, K. A. (2010) · American Journal of Human Biology · doi:10.1002/ajhb.21079 · Cited by 61
“This comes at a cost: not only is muscle energetically expensive (Lassek and Gaulin, 2009), but high levels of testosterone also increase the catabolism of fat tissues, depleting reserves that could be essential during periods of food shortage (Bhasin et al., 2005).”
Androgen Physiology, Pharmacology, and Abuse
Handelsman, D. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00138-4 · Cited by 66
Macdonald, J. H., Marcora, S., Jibani, M. M., Kumwenda, M. J., Ahmed, W., & LEMMEY, A. B. (2007) · Nephron Clinical Practice · doi:10.1159/000103000 · Cited by 57
Adverse health effects of testosterone deficiency (TD) in men
Traish, A. M. (2014) · Steroids · doi:10.1016/j.steroids.2014.05.010 · Cited by 53
The low male voice is a costly signal of phenotypic quality among Bolivian adolescents
Hodges‐Simeon, C. R., Gurven, M., & Gaulin, S. J. C. (2015) · Evolution and Human Behavior · doi:10.1016/j.evolhumbehav.2015.01.002 · Cited by 55
“Evidence indicates that T decreases fat mass by upregulating adipose catabolism (Bhasin et al., 2005), suggesting that T both affects and is affected by the amount of adipose tissue.”
BackgroundTrumble, B. C., Cummings, D. K., O’Connor, K. A., Holman, D. J., Smith, E. A., Kaplan, H. S., & Gurven, M. (2013) · Evolution and Human Behavior · doi:10.1016/j.evolhumbehav.2013.06.002 · Cited by 54
“Studies of testosterone supplementation show that the muscles of older males are as responsive as young men to physiological effects of testosterone (Bhasin et al., 2005).”
BackgroundTan, W. S., Low, W. Y., Ng, C. J., Tan, W. K., Tong, S. F., Ho, C. C. K., Khoo, E. M., Lee, G., Lee, B. C., Lee, V., et al. (2013) · British Journal of Urology · doi:10.1111/bju.12037 · Cited by 52
Supraphysiologic-dose anabolic–androgenic steroid use: A risk factor for dementia?
Kaufman, M. J., Kanayama, G., Hudson, J. I., & Pope, H. G. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.02.014 · Cited by 65
Lee, N. K. L., Skinner, J. P. J., Zajac, J. D., & MacLean, H. E. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00094.2011 · Cited by 52
“In addition, androgens can have anabolic actions in muscle in adult males, with clinical studies demonstrating a dose-dependent response of skeletal muscle to exogenously administered testosterone in young and elderly men, with increases in muscle size, strength, and fiber hypertrophy (12, 13).”
Yarrow, J. F., Conover, C. F., Purandare, A. V., Bhakta, A. M., Zheng, N. N., Conrad, B. P., Altman, M. K., Franz, S. E., Wronski, T. J., & Borst, S. E. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90640.2008 · Cited by 54
“istration, including elevated hematocrit, leg edema, and increased incidence of prostatic events (6).”
BackgroundAndrogenic-anabolic steroids and the Olympic Games
Fitch, K. D. (2008) · Asian Journal of Andrology · doi:10.1111/j.1745-7262.2008.00377.x · Cited by 60
Hormones and acoustic communication in anuran amphibians
Leary, C. J. (2009) · Integrative and Comparative Biology · doi:10.1093/icb/icp027 · Cited by 55
Bogaert, V., Taes, Y., Konings, P., Van Steen, K., De Bacquer, D., Goemaere, S., Zmierczak, H., Crabbe, P., & Kaufman, J. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03173.x · Cited by 50
Women with polycystic ovary syndrome have greater muscle strength irrespective of body composition
Kogure, G. S., Silva, R. C., Picchi Ramos, F. K., Miranda-Furtado, C. L., Lara, L. A. D. S., Ferriani, R. A., & dos Reis, R. M. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2014.982083 · Cited by 49
“A recent study by our team showed that women with PCOS have greater muscle strength [6], suggesting that androgens could increase muscle mass and may promote free-fat muscle gain and muscle strength [7].”
BackgroundTraish, A. M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-70178-3_22 · Cited by 58
Mou, K., Chan, S. M. H., & Vlahos, R. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108635 · Cited by 59
Acute testosterone deprivation reduces insulin sensitivity in men
Rubinow, K. B., Snyder, C. N., Amory, J. K., Hoofnagle, A. N., & Page, S. T. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04189.x · Cited by 48
Yarrow, J. F., Conover, C. F., McCoy, S. C., Lipinska, J. A., Santillana, C. A., Hance, J. M., Cannady, D. F., VanPelt, T. D., Sanchez, J., Conrad, B. P., et al. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00440.2010 · Cited by 53
“In contrast, supraphysiological testosterone effectively augments skeletal muscle mass (7, 8, 57), reduces adiposity (65), and increases BMD (2) in men and in orchiectomized animal models (10, 66) but also increases the risk for a variety of side effects, of which polycythemia, prostate enlargement, and increased inci…”
BackgroundCharacterization of the male ApcMin/+ mouse as a hypogonadism model related to cancer cachexia
White, J. P., Puppa, M. J., Narsale, A., & Carson, J. A. (2013) · Biology Open · doi:10.1242/bio.20136544 · Cited by 47
The Current Understanding of Sarcopenia: Emerging Tools and Interventional Possibilities
Delmonico, M. J., & Beck, D. T. (2016) · American Journal of Lifestyle Medicine · doi:10.1177/1559827615594343 · Cited by 61
“Studies reporting more substantial effects of testosterone replacement therapy (TRT) administer testosterone at higher than physiologic replacement dosages and administered via intramuscular injection.(103,104) Collectively, research suggests that the beneficial effects of TRT”
BackgroundTestosterone in older men after the Institute of Medicine Report: where do we go from here?
Harman, S. (2005) · Climacteric · doi:10.1080/13697130500118001 · Cited by 47
Rodriguez‐Tolrà, J., Torremadé, J., di Gregorio, S., del Rio, L., & Franco, E. (2013) · Andrology · doi:10.1111/j.2047-2927.2013.00090.x · Cited by 46
“While some authors have reported no significant increases in PSA levels with testosterone treatment (Bhasin et al., 2005; Allan et al., 2008), others have reported changes (Kenny et al.”
BackgroundPartial Androgen Deficiency, Depression, and Testosterone Supplementation in Aging Men
Amore, M., Innamorati, M., Costi, S., Sher, L., Girardi, P., & Pompili, M. (2012) · International Journal of Endocrinology · doi:10.1155/2012/280724 · Cited by 55
Bouloux, P. M. G., Legros, J.-J., Elbers, J. M. H., Geurts, T. B. P., Kaspers, M. J. G. H., Meehan, A. G., Meuleman, E. J. H., & and for the Study 43203 Investigators (2013) · The Aging Male · doi:10.3109/13685538.2013.773420 · Cited by 46
“Similar to the effects on LBM, testosterone generally has a dose-dependent effect on BFM [8].”
BackgroundTestosterone replacement therapy for older men
Borst, S. E., & Mulligan, T. (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s1609 · Cited by 59
“However, the study that best demonstrates the dose dependence is that of Bhasin et al (2005).”
Pathogen evolution in a vaccinated world
Read, A. F., & Mackinnon, M. J. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0011 · Cited by 51
Frailty and Muscle Function: Role for Testosterone?
Srinivas-Shankar, U., & Wu, F. C. W. (2008) · Frontiers of Hormone Research · doi:10.1159/000176050 · Cited by 45
Benefits and Health Implications of Testosterone Therapy in Men With Testosterone Deficiency
Traish, A. M. (2017) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2017.10.001 · Cited by 48
“TTh in men with medically induced TD results in a dose-dependent increase in muscle mass and a decrease in FM.15,19 It is widely acknowledged that TTh in men with TD increases LBM and decreases FM.”
BackgroundFrost, R. A., & Lang, C. H. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.04.012 · Cited by 44
Chen, M., Han, D., Yang, J., Yang, Y., Ho, H., & Yang, W. (2012) · Human Reproduction · doi:10.1093/humrep/des209 · Cited by 47
“Androgens, such as testosterone and DHEA/DHEAS, alone or in combination with exercise, have been shown to increase muscle mass and strength in young and aging men (Bhasin et al., 1996; Bhasin et al., 2005), and elderly women (Kenny et al.”
Physical exercise, nutrition and hormones: three pillars to fight sarcopenia
Sgrò, P., Sansone, M., Sansone, A., Sabatini, S., Borrione, P., Romanelli, F., & Luigi, L. D. (2018) · The Aging Male · doi:10.1080/13685538.2018.1439004 · Cited by 55
“However, side effects should be carefully evaluated during TRT, especially if the established target is defined as above [123].”
BackgroundCoviello, A. D., Lakshman, K., Mazer, N. A., & Bhasin, S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0822 · Cited by 44
Self-citationYeap, B. B., Page, S. T., & Grossmann, M. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30416-3 · Cited by 45
Tallis, J., Shelley, S., Degens, H., & Hill, C. (2021) · Biomolecules · doi:10.3390/biom11030372 · Cited by 41
Androgen deficiency: effects on body composition
Miller, K. K. (2008) · Pituitary · doi:10.1007/s11102-008-0121-7 · Cited by 49
“The study demonstrated that androgen deprivation in healthy elderly men is associated with similar decrements in lean body mass as those in younger hypogonadal men, but without the concomitant increase in body fat observed in their younger counterparts [25].”
ResultAnabolic effects of testosterone are preserved during inhibition of 5α-reductase
Borst, S. E., Conover, C. F., Carter, C. S., Gregory, C. M., Marzetti, E., Leeuwenburgh, C., Vandenborne, K., & Wronski, T. J. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00130.2007 · Cited by 43
“In comparison, human replacement doses are in the range of 35–100 mg/wk (10, 15, 27, 36), and the highest dose administered to humans is 600 mg/wk (5).”
BackgroundThe ecology and evolution of antibiotic-resistant bacteria
Bergstrom, C. T., & Feldgarden, M. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0010 · Cited by 50
Testosterone Replacement Therapy in Hypogonadal Men
Wang, C., & Swerdloff, R. S. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.11.005 · Cited by 54
Partial androgen deficiency, depression and testosterone treatment in aging men
Amore, M., Scarlatti, F., Quarta, A. L., & Tagariello, P. (2009) · Aging Clinical and Experimental Research · doi:10.1007/bf03324891 · Cited by 45
Muscular Transcriptome in Postmenopausal Women With or Without Hormone Replacement
Pöllänen, E., HA Ronkainen, P., Suominen, H., Takala, T., Koskinen, S., Puolakka, J., Sipilä, S., & Kovanen, V. (2007) · Rejuvenation Research · doi:10.1089/rej.2007.0536 · Cited by 41
Swerdloff, R. S., Pak, Y., Wang, C., Liu, P. Y., Bhasin, S., Gill, T. M., Matsumoto, A. M., Pahor, M., Surampudi, P., & Snyder, P. J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1542 · Cited by 39
“Although high-quality evidence-based data to demonstrate a causal relationship are not available, higher serum T levels could be associated with dose-related adverse events (ie, erythrocytosis and cardiovascular events) (6, 7), especially in frail older men.”
BackgroundSelf-citationAge related variation of salivary testosterone values in healthy Japanese males
Uchida, A., Bribiescas, R. G., Ellison, P. T., Kanamori, M., Ando, J., Hirose, N., & Ono, Y. (2006) · The Aging Male · doi:10.1080/13685530601060461 · Cited by 39
“The significance of androgens in older male cognitive function as well as physical maintenance such as bone density and muscle mass has been widely reported [20,27,43–48].”
Background
Metadata
- Authors
- Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Mac, R. P., Lee, M., Yarasheski, K. E., Sinha-Hikim, I., Dzekov, C., Dzekov, J., Magliano, L., & Storer, T. W.
- Affiliations
- University of California, Los Angeles (US)
- Charles R. Drew University of Medicine and Science (US)
- Washington University in St. Louis (US)
- El Camino College (US)
- Corresponding author
- Bhasin, Shalender
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-02
- Volume
- 90
- Issue
- 2
- Pages
- 678-688
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2133467178
- Cited by
- 544
- References
- 73
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 23 · 2023: 16 · 2022: 30 · 2021: 13 · 2020: 19 · 2019: 17 · 2018: 30 · 2017: 28 · 2016: 17 · 2015: 19 · 2014: 22 · 2013: 29 · 2012: 22
- FWCI
- 28.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p41rr000954-34, 5u01dk054047-06)
- National Institute on Aging (1R01 AG-14369-01, R01AG014369)
- National Institute of General Medical Sciences (GM-00425)
- National Institute of Diabetes and Digestive and Kidney Diseases (1R01 DK 59627-01, U01-DK-54047, R01DK049296, 2R01DK49296-02A, R01DK059627)
- National Center for Research Resources (G12 RR 03026, P41-RR000954, P20RR11145, 5P41-RR-000954, G12RR003026, P20RR011145)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD041748, R01HD043348)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Keywords
- older men, androgen response, skeletal muscle, fat-free mass, fat mass, muscle strength, sexual function, mood, visuospatial cognition, GnRH agonist, testosterone replacement therapy, aging, hemoglobin response, adverse effects, treatment discontinuation
- MeSH terms
- Adult, Age Factors, Aged, Aging, Energy Intake, Exercise Test, Humans, Luteinizing Hormone, Male, Middle Aged, Sexual Behavior, Sex Hormone-Binding Globulin, Testosterone, Leuprolide, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.